Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently, the functions of circular RNAs (circRNAs) on cancer initiation and development arouse wide concern. Herein, we tested the influences of circ-
ZNF652
on renal carcinoma cell growth and metastasis. Firstly, clinical renal carcinoma tissues and corresponding normal tissues were collected. The circ-
ZNF652
expressions were tested. Then, the influences of silencing circ-
ZNF652
on renal carcinoma A498 and ACHN cell proliferation, apoptosis and epithelial-mesenchymal transition (EMT) process, as well as Ras/Raf/
MEK
/ERK and JAK1/STAT3 pathways, were probed. Finally, whether miR-205 engaged in the influences of silencing circ-
ZNF652
on A498 and ACHN cell were investigated. circ-
ZNF652
had high expression level in clinical renal carcinoma tissues. Silencing circ-
ZNF652
repressed A498 and ACHN cell proliferation and EMT process, but promoted cell apoptosis. Moreover, silencing circ-
ZNF652
suppressed Ras/Raf/
MEK
/ERK and JAK1/STAT3 pathways in A498 and ACHN cells. Besides, the miR-205 expressions in A498 and ACHN cells were raised by silencing circ-
ZNF652
. Knockdown of miR-205 weakened the influences of silencing circ-
ZNF652
on A498 and ACHN cell proliferation, apoptosis and EMT process. Silencing circ-
ZNF652
repressed proliferation and EMT process of renal carcinoma A498 and ACHN cells
via
suppressing Ras/Raf/
MEK
/ERK and JAK1/STAT3 pathways, as well as raising miR-205 expression.
...
PMID:Silencing circular RNA-ZNF652 represses proliferation and EMT process of renal carcinoma cells via raising miR-205. 3308 30